Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06862128 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OGTT at Home Using CGM vs at the Clinic

Study acronym: OGTT-CGM
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing Enrollment target: estimated 75 to confirmed 70 · Primary completion date changed from estimate of May 31, 2026 to May 21, 2026 · Eligibility criteria shortened, about 22 words · 2 morev6 Show 5 more changesShow less
    • Enrollment target: estimated 75 to confirmed 70
    • Primary completion date changed from estimate of May 31, 2026 to May 21, 2026
    • Eligibility criteria shortened, about 22 words
    • Study description shortened, about 15 words
    • Site details revised at 3 of 3 sites

    See this version in full on ClinicalTrials.gov ↗

  2. Primary endpoint(s) modified Secondary endpoints: 3 to 2v5 Show 1 more changeShow less
    • Secondary endpoints: 3 to 2

    See this version in full on ClinicalTrials.gov ↗

  3. Primary endpoints: 2 to 1 Primary completion date: Dec 31, 2025 to May 31, 2026 · Secondary endpoints: 2 to 3v4 Show 2 more changesShow less
    • Primary completion date: Dec 31, 2025 to May 31, 2026
    • Secondary endpoints: 2 to 3

    See this version in full on ClinicalTrials.gov ↗

  4. Eligibility criteria shortened, about 37 wordsv3 See this version in full on ClinicalTrials.gov ↗
  5. Trial status: Not Yet Recruiting to Recruiting Completion date: Dec 31, 2025 to Dec 31, 2040 · Start date changed from estimate of Apr 1, 2025 to Jun 11, 2025 · Site details revised at 3 of 3 sitesv2 Show 3 more changesShow less
    • Completion date: Dec 31, 2025 to Dec 31, 2040
    • Start date changed from estimate of Apr 1, 2025 to Jun 11, 2025
    • Site details revised at 3 of 3 sites
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Linkoeping University
55 trials monitored
See 3 trials at risk
Diabetes
4,286 trials monitored
See 187 trials at risk
This randomized, crossover study evaluates the feasibility and accuracy of a self-administered oral glucose tolerance test (OGTT) at home using continuous glucose monitoring (CGM) compared to a standard clinic-based OGTT. Participants with prediabetes will undergo both home-based and clinic-based OGTTs, with glucose levels measured via CGM and venous plasma glucose. The primary outcome is the correlation between CGM-based glucose values and standard OGTT results. Secondary outcomes include diagnostic agreement, metabolic hormone associations, and feasibility of home-based testing as a diagnostic tool for dysglycemia.
Trial Details
NCT Number NCT06862128
Lead Sponsor Linkoeping University
Collaborators: Region Jönköping County, Region Östergötland
Conditions Pre-diabetes, Diabetes
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov